Company Filing History:
Years Active: 2013-2021
Title: Isamu Terashima: Innovator in Biopharmaceuticals
Introduction
Isamu Terashima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of methods for producing humanized antibodies. With a total of 4 patents to his name, Terashima continues to push the boundaries of innovation in his field.
Latest Patents
One of Terashima's latest patents is a process of production with controlled copper ions. This invention provides a method of cell culture that involves adding a cell-containing seed medium to an initial medium. The initial medium is enhanced with an organism-derived culture medium additive, allowing for the control of the C-terminal amidated species in the produced protein based on the copper content at the start of cell culture. Another notable patent is focused on methods for producing subtypes of humanized antibodies against the interleukin-6 receptor. This patent describes two specific antibody subtypes, which are variants of the humanized PM-1 antibody, and includes a pharmaceutical composition comprising these subtypes.
Career Highlights
Isamu Terashima is currently employed at Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work there has been instrumental in advancing the company's research and development efforts in biopharmaceuticals.
Collaborations
Throughout his career, Terashima has collaborated with notable colleagues, including Katsuhiro Kano and Seiko Yamamoto. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Isamu Terashima is a key figure in the biopharmaceutical industry, with a focus on innovative methods for antibody production. His contributions through patents and collaborations continue to impact the field significantly.